Promotora Y Operadora de Infraestructura SAB de CV Vs. Keros Therapeutics Industry Stock Comparison

Buy

55

PUODY
Promotora Y Operadora de Infraestructura SAB de CV

Last Price:

187.14

Seasonality Move:

2.16%

Sell

27

KROS
Keros Therapeutics

Last Price:

45.71

Seasonality Move:

-4.71%

Buy

55

Promotora Y Operadora de Infraestructura SAB de CV (PUODY) is a Buy

Is Promotora Y Operadora de Infraestructura SAB de CV a Buy, Sell or Hold?

The current Promotora Y Operadora de Infraestructura SAB de CV [PUODY] share price is $187.14. The Score for PUODY is 55, which is 10% above its historic median score of 50, and infers lower risk than normal.
PUODY is currently trading in the 50-60% percentile range relative to its historical Stock Score levels.
This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.

Sell

27

Keros Therapeutics (KROS) is a Sell

Is Keros Therapeutics a Buy, Sell or Hold?

The current Keros Therapeutics [KROS] share price is $45.70. The Score for KROS is 27, which is 46% below its historic median score of 50, and infers higher risk than normal.
KROS is currently trading in the 20-30% percentile range relative to its historical Stock Score levels.
This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.

PUODY Stock Price Chart

What is Promotora Y Operadora de Infraestructura SAB de CV's stock price today?

The Promotora Y Operadora de Infraestructura SAB de CV share price today is $187.14
Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and PUODY is experiencing slight buying pressure.

KROS Stock Price Chart

What is Keros Therapeutics's stock price today?

The Keros Therapeutics share price today is $45.70
Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and KROS is experiencing slight buying pressure.

PUODY Technical Analysis

Chart Indicators	Level	Buy or Sell
MACD (12, 26):	-6.88	Sell
Relative Strength Index (14 RSI):	38.94	Sell
Chaikin Money Flow:	0	-

Bollinger Bands	Level	Buy or Sell
Bollinger Bands (25):	(185.88 - 215.78)	Sell
Bollinger Bands (100):	(199.25 - 222.93)	Sell

KROS Technical Analysis

Chart Indicators	Level	Buy or Sell
MACD (12, 26):	-1.79	Sell
Relative Strength Index (14 RSI):	38.41	Sell
Chaikin Money Flow:	239305	-

Bollinger Bands	Level	Buy or Sell
Bollinger Bands (25):	(45.72 - 49.1)	Sell
Bollinger Bands (100):	(49.87 - 64.91)	Sell

PUODY Moving Averages

Moving Averages	Level	Buy or Sell
8-day SMA:	190.34	Sell
20-day SMA:	194.89	Sell
50-day SMA:	208.02	Sell
200-day SMA:	200.45	Sell
8-day EMA:	189.78	Sell
20-day EMA:	195.98	Sell
50-day EMA:	204.38	Sell
200-day EMA:	203.3	Sell

KROS Moving Averages

Moving Averages	Level	Buy or Sell
8-day SMA:	45.61	Buy
20-day SMA:	47.29	Sell
50-day SMA:	51.65	Sell
200-day SMA:	47.07	Sell
8-day EMA:	45.93	Sell
20-day EMA:	47.34	Sell
50-day EMA:	50.89	Sell
200-day EMA:	50	Sell

Promotora Y Operadora de Infraestructura SAB de CV Earnings Growth & PUODY Earnings Dates

Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.00 per share, and a decrease next year of $0.00 per share.

Keros Therapeutics Earnings Growth & KROS Earnings Dates

Analysts estimate an earnings increase this quarter of $0.06 per share, an increase next quarter of $0.03 per share, an increase this year of $0.35 per share, and a decrease next year of $0.39 per share.

Promotora Y Operadora de Infraestructura SAB de CV Technical Analysis

	Jun 14	Jun 17	Jun 18	Jun 20	Jun 21	Jun 24	Jun 25	Jun 26	Jun 27	Jun 28
	Jun
	14	17	18	20	21	24	25	26	27	28
Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

Keros Therapeutics Technical Analysis

	Jun 14	Jun 17	Jun 18	Jun 20	Jun 21	Jun 24	Jun 25	Jun 26	Jun 27	Jun 28
	Jun
	14	17	18	20	21	24	25	26	27	28
Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):